Cointime

DBV Technologies

company

About

DBV Technologies focuses on the development of innovative products for the diagnosis and treatment of food allergies.

  • 51 - 100

Highlights

Total Funding Amount
$25.50M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series C
Last Funding Money Raised
$25.50M
Industries
Biopharma,Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2002
Number Of Employee
51 - 100
Operating Status
Active

DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians and entrepreneurs who believed that food allergies could one day be treated safely and effectively. With this mission driving their commitment to the advancement of treatments in this field, they are investigating a potential new class of immunotherapy that aims to activate the immune system of patients through the skin.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$25.50M
DBV Technologies has raised a total of $25.50M in funding over 2 rounds. Their latest funding was raised on Jan 5, 2011 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 5, 2011 Series C $25.50M 1 InnoBio Fund — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
DBV Technologies is funded by 1 investors. InnoBio Fund are the most recent investors.
Investor Name Lead Investor Funding Round
InnoBio Fund Yes Series C
Cointime
เนื้อหา
บริษัท